previously untreated patients with myeloma were randomized to initial treatment with melphalan and prednisone ( and to cyclophosphamide or carmustine if relapse or progression occurred ) ( group a , 125 patients ) , melphalan , cyclophosphamide , carmustine and prednisone in alternating ( group b , 123 patients ) or concurrent ( group c , 116 patients ) schedules .
C0026764
myeloma
C0007257
carmustine